Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA05000557 (9Z,12Z)-octadecadien-1-ol (9Z,12Z)-octadeca-9,12-dien-1-ol FOH 18:2 C18H34O 266.260966
LMFA01030949 (E)-10-Oxo-8-decenoic acid (8E)-10-oxodec-8-enoic acid FA 10:2;O C10H16O3 184.109945
LMFA05000551 (2S)-octan-2-ol (2S)-octan-2-ol FOH 8:0 C8H18O 130.135765
LMFA05000621 2-Undecanol undecan-2-ol FOH 11:0 C11H24O 172.182715
LMFA02030021 16-F1c-PhytoP 8-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)octanoic acid FA 18:2;O3 C18H32O5 328.224976
LMFA02030018 ent-9-epi-9-F1c-PhytoP (S,E)-11-((1S,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-9-hydroxyundec-10-enoic acid FA 18:2;O3 C18H32O5 328.224976
LMFA04020099 (10S,13R,17R)-d15-11-NeuroF[11S,14R] (S,4Z,7Z)-10-hydroxy-10-((2S,4R,5R)-4-hydroxy-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA02030045 9-E1c-PhytoP (S,E)-11-((1R,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-9-hydroxyundec-10-enoic acid FA 18:3;O3 C18H30O5 326.209326
LMFA03110276 ent-8-epi-5-J2-IsoP (R,E)-5-hydroxy-7-((R,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid FA 20:5;O2 C20H30O4 334.214411
LMFA07030011 Type IV cyanolipid 20:2 ester (1-cyano-2-methylprop-2-en-1-yl) 11Z,14Z-eicosadienoate C25H41NO2 387.313729
LMFA07030011 Type IV cyanolipid 20:2 ester (1-cyano-2-methylprop-2-en-1-yl) 11Z,14Z-eicosadienoate C25H41NO2 387.313729
LMFA07030011 Type IV cyanolipid 20:2 ester (1-cyano-2-methylprop-2-en-1-yl) 11Z,14Z-eicosadienoate C25H41NO2 387.313729
LMFA03110337 ent-10,17-diepi-17-F2c-dihomo-IsoP 1a,1b-dihomo-11R,13S,17S-trihydroxy-7Z,15E-prostadienoic acid-cyclo[10R,14R] FA 22:3;O3 C22H38O5 382.271926
LMFA01050548 9,10-Dihydroxydocosanoic acid 9,10-Dihydroxydocosanoic acid FA 22:0;O2 C22H44O4 372.323961
LMFA01050548 9,10-Dihydroxydocosanoic acid 9,10-Dihydroxydocosanoic acid FA 22:0;O2 C22H44O4 372.323961
LMFA08020163 1-(4-carboxybutanamido)-1'-(dimethylcarbamoyl)ferrocene {(1,2,3,4,5-eta)-1-(4-carboxybutanamido)cyclopentadienyl}[(1,2,3,4,5-eta)-1-(dimethylcarbamoyl)cyclopentadienyl]iron C18H22N2O4Fe 386.092898
LMFA08020163 1-(4-carboxybutanamido)-1'-(dimethylcarbamoyl)ferrocene {(1,2,3,4,5-eta)-1-(4-carboxybutanamido)cyclopentadienyl}[(1,2,3,4,5-eta)-1-(dimethylcarbamoyl)cyclopentadienyl]iron C18H22N2O4Fe 386.092898
LMFA08020175 Ferroxamine N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxo-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-butanediamide;iron C25H48FeN6O8 616.288303
LMFA08020175 Ferroxamine N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxo-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-butanediamide;iron C25H48FeN6O8 616.288303
LMFA02040125 (9S,12S,16R)-d14-10-PhytoF[10R,13R] (S)-9-hydroxy-9-((2R,4S,5R)-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)nonanoic acid FA 18:2;O4 C18H32O6 344.219891
LMFA03110338 ent-10,17-diepi-17-F2t-dihomo-IsoP 1a,1b-dihomo-11R,13S,17S-trihydroxy-7Z,15E-prostadienoic acid-cyclo[10S,14S] FA 22:3;O3 C22H38O5 382.271926
LMFA07010089 Myristoleyl laurate 9Z-tetradecenyl dodecanoate WE 26:1 C26H50O2 394.381081
LMFA07010089 Myristoleyl laurate 9Z-tetradecenyl dodecanoate WE 26:1 C26H50O2 394.381081
LMFA08020256 N-gondoyl taurine N-(11Z-eicosenoyl) taurine NAT 20:1 C22H43NO4S 417.291280
LMFA01031033 Bosseopentaenoic acid 5Z,8Z,10E,12E,14Z-eicosapenta-enoic acid FA 20:5 C20H30O2 302.224581
LMFA01050450 (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid FA 17:3;O3 C17H28O5 312.193676
LMFA01050450 (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid FA 17:3;O3 C17H28O5 312.193676
LMFA01050450 (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid FA 17:3;O3 C17H28O5 312.193676
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA07070013 (2E)-hexenedioylcarnitine 3-{[(2E)-5-carboxypent-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 6:2;O2 C13H21NO6 287.136889
LMFA07070013 (2E)-hexenedioylcarnitine 3-{[(2E)-5-carboxypent-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 6:2;O2 C13H21NO6 287.136889
LMFA07070058 Clupanodonyl carnitine 3-[(4E,8E,12E,15E,19E)-docosa-4,8,12,15,19-pentaenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:5 C29H47NO4 473.350510
LMFA07070058 Clupanodonyl carnitine 3-[(4E,8E,12E,15E,19E)-docosa-4,8,12,15,19-pentaenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:5 C29H47NO4 473.350510
LMFA07070041 3-hydroxyisovalerylcarnitine 3-[(3-hydroxy-3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0;O C12H23NO5 261.157624
LMFA07070041 3-hydroxyisovalerylcarnitine 3-[(3-hydroxy-3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0;O C12H23NO5 261.157624
LMFA07070041 3-hydroxyisovalerylcarnitine 3-[(3-hydroxy-3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0;O C12H23NO5 261.157624
LMFA07070051 Acylcarnitine C18:0 3-stearoyloxy-4-(trimethylammonio)butyrate CAR 18:0 C25H49NO4 427.366160
LMFA08020274 N-(7Z,10Z,13Z-16Z-docosatetraenoyl) dopamine N-(7Z,10Z,13Z-16Z-docosatetraenoyl) dopamine NA 30:8;O2 C30H45NO3 467.339944
LMFA12000278 9R,10S-epoxy-3Z,6Z-heptadecadiene 9R,10S-epoxy-3Z,6Z-heptadecadiene C17H30O 250.229666
LMFA07070064 Fumarycarnitine (3S)-3-{[(2E)-3-carboxyprop-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 4:2;O2 C11H17NO6 259.105589
LMFA07070064 Fumarycarnitine (3S)-3-{[(2E)-3-carboxyprop-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 4:2;O2 C11H17NO6 259.105589
LMFA07070066 Glutarylcarnitine (3S)-3-[(4-carboxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:1;O2 C12H21NO6 275.136889
LMFA07070088 O-arachidonoylcarnitine 3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 20:4 C27H45NO4 447.334859
LMFA07070088 O-arachidonoylcarnitine 3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 20:4 C27H45NO4 447.334859
LMFA07070096 O-oleoylcarnitine 3-[(9Z)-octadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 18:1 C25H47NO4 425.350510
LMFA07070096 O-oleoylcarnitine 3-[(9Z)-octadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 18:1 C25H47NO4 425.350510
LMFA07010852 Ethyl 2E-hexenoate ethyl hex-2-enoate SFE 8:1 C8H14O2 142.099380